Arthcal 4% Lidocaine Gel Patches Patch
Product Images NDC 85212-0005

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Arthcal 4% Lidocaine Gel Patches (NDC 85212-0005). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Beijing Junge Technology Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4% Lidocaine Gel Patches (20250218 113113)

4% Lidocaine Gel Patches (20250218 113113)
This is a description of a pain relief patch with maximum strength lidocaine as the active ingredient. The patch provides odorless relief for up to 8 hours and is designed for external use only in adults and children over 12 years old. It offers fast-acting pain relief and targets aggravated nerves by desensitizing them. The product should not be used on raw surfaces or blistered areas. The patch should be applied to the affected area with the sticky side adhering to the skin. It is recommended to use only as directed and to discard the patch after a single use. The patch should be stored in a clean, dry place away from direct sunlight. If there are any adverse reactions, it is advised to stop use and consult a doctor.*
FDA Label Image

2e63482e 5438 42b4 E063 6394a90a2bbf

2e63482e 5438 42b4 E063 6394a90a2bbf
The text provides information about a Pain Relief Patch with a 4% Lidocaine formulation, offering odorless relief for up to 8 hours. It is suitable for adults and children 12 years and older for temporary pain relief. Directions caution against using on raw or blistered skin and advise against using multiple patches at the same time or with other topical analgesics. The product is designed for fast-acting deep penetration to relieve pain and desensitize aggravated nerves. Additional notes include safety precautions, such as avoiding contact with eyes and keeping the patch out of reach of children. The patch should be discarded after single use. If adverse reactions occur, it is recommended to stop use and seek medical advice.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.